[{"Assets_0_Q2_USD":287669000.0,"CommonStockSharesOutstanding_0_Q2_shares":149885000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20810000.0,"NetIncomeLoss_1_Q2_USD":-43446000.0,"NetIncomeLoss_2_Q2_USD":-87197000.0,"StockholdersEquity_0_Q2_USD":-68174000.0,"Ticker":"IMGN","CIK":"855654","name":"IMMUNOGEN, INC.","OfficialName":"ImmunoGen Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148965984.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]